FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Nevada Man Pleads Guilty to Importing and Selling Misbranded Drugs

[ Price : $8.95]

A Nevada businessman enters guilty plea to importing and distributing misbranded prescription erectile dysfunction drugs from Indi...

Study Finds Compounded GLP-1 Market Remains Strong Despite FDA Crackdown

[ Price : $8.95]

A new study published in JAMA Health Forum suggests the market for compounded GLP-1 weight-loss drugs remains robust despite the F...

FDA Cites Charles River Endosafe Lab Over Quality System Deficiencies

[ Price : $8.95]

FDA issues a Form-483 to Charles River Laboratories' Endosafe contract testing laboratory in Charleston, SC, over multiple quality...

Friendly Accelerated Approval Disclosures Improve Drug Understanding: Study

[ Price : $8.95]

A new study suggests that direct-to-consumer prescription drug Web sites may better communicate the limitations of FDA accelerated...

Fujifilm Diosynth Cited Over NC Plants Microbial Contamination Controls

[ Price : $8.95]

FDA cites Fujifilm Diosynth Biotechnologies USA for significant manufacturing deficiencies at its drug substance facility in Resea...

Camurus NDA Resubmission for Acromegaly Therapy Accepted by FDA

[ Price : $8.95]

FDA accepts for review a Camurus NDA resubmission for Oclaiz (octreotide), a long-acting injection for treating acromegaly.

Class I Recall of Bolton Medicals Relay Pro Thoracic Stent Graft System

[ Price : $8.95]

Bolton Medical recalls its Relay Pro Thoracic Stent Graft Systems due to reports of a deployment failure that may result in seriou...

13 Observations in Zhejiang Hushai Inspection

[ Price : $8.95]

FDA releases the form FDA-483 with 13 observations from an April inspection at Chinas Zhejiang Hushai Pharmaceutical Co.

Active Drug Shortages Still Trending Up

[ Price : $8.95]

The American Society of Health System Pharmacists says there were 227 active drug shortages in the second quarter of 2026, trendin...

FDA Reevaluating Makarys Journal Articles, Podium Policies: DeGette

[ Price : $8.95]

Rep. Diana DeGette (D-CO) wins FDA assurances that several policy announcements issued during former commissioner Marty Makary's t...